Ontario Teachers Pension Plan Board Has $24.45 Million Stake in SPDR S&P Biotech ETF (XBI)

Ontario Teachers Pension Plan Board lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 255,000 shares of the exchange traded fund’s stock after buying an additional 30,000 shares during the period. Ontario Teachers Pension Plan Board owned approximately 0.45% of SPDR S&P Biotech ETF worth $24,447,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bruderman Asset Management LLC increased its holdings in SPDR S&P Biotech ETF by 15.2% during the 3rd quarter. Bruderman Asset Management LLC now owns 56,773 shares of the exchange traded fund’s stock valued at $5,443,000 after purchasing an additional 7,509 shares during the period. FMR LLC increased its holdings in SPDR S&P Biotech ETF by 2.4% during the 3rd quarter. FMR LLC now owns 40,967 shares of the exchange traded fund’s stock valued at $3,927,000 after purchasing an additional 975 shares during the period. Oak Grove Capital LLC increased its holdings in SPDR S&P Biotech ETF by 30.7% during the 3rd quarter. Oak Grove Capital LLC now owns 12,550 shares of the exchange traded fund’s stock valued at $1,203,000 after purchasing an additional 2,950 shares during the period. Rafferty Asset Management LLC increased its holdings in SPDR S&P Biotech ETF by 114.1% during the 3rd quarter. Rafferty Asset Management LLC now owns 941,464 shares of the exchange traded fund’s stock valued at $90,258,000 after purchasing an additional 501,695 shares during the period. Finally, Ahrens Investment Partners LLC increased its holdings in SPDR S&P Biotech ETF by 80.3% during the 3rd quarter. Ahrens Investment Partners LLC now owns 7,093 shares of the exchange traded fund’s stock valued at $680,000 after purchasing an additional 3,158 shares during the period.

Shares of NYSEARCA:XBI opened at $77.62 on Friday. SPDR S&P Biotech ETF has a 1 year low of $73.97 and a 1 year high of $101.55.

ILLEGAL ACTIVITY WARNING: This article was posted by WKRB News and is owned by of WKRB News. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://www.wkrb13.com/2018/11/23/ontario-teachers-pension-plan-board-has-24-45-million-stake-in-spdr-sp-biotech-etf-xbi.html.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: Institutional Investors

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply